Novel Biomarkers Assessing the Calcium Deposition in Coronary Artery Disease

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|19|6|901-920

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.19, Iss.6, 2012-02, pp. : 901-920

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel Anti-Platelets in Stable Coronary Artery Disease

By  

Current Pharmaceutical Design, Vol. 22, Iss. 29, 2016-09 ,pp. : 4537-4567

Bentham Science Publishers

Access to resources Recommend Favorite

Can microRNAs be Biomarkers or Targets for Therapy of Ischemic Coronary Artery Disease in Metabolic Syndrome?

By  

Current Drug Targets, Vol. 18, Iss. 15, 2017-10 ,pp. : 1722-1732

Bentham Science Publishers

Access to resources Recommend Favorite

Oxidized-LDL and Paraoxonase-1 As Biomarkers of Coronary Artery Disease in Patients with Sleep-Disordered Breathing

By  

Current Medicinal Chemistry, Vol. 19, Iss. 25, 2012-09 ,pp. : 4359-4366

Bentham Science Publishers

Access to resources Recommend Favorite

Perindopril is beneficial among patients with stable coronary artery disease who are receiving calcium channel blockers

By  

Inpharma, Vol. 1, Iss. 1654, 2008-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Has the controversy over the use of calcium channel blockers in coronary artery disease been resolved?

By Doggrell Sheila A  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 5, 2005-05 ,pp. : 831-834

Informa Healthcare

Access to resources Recommend Favorite